Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Diehm

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 30, 2008
[Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease]H Darius, H J Trampisch, D Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)|May 19, 1989
[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]C Diehm, O Abri, G Baitsch, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1983
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases]H U Comberg, E J Janssen, C Diehm, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 4, 2004
High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetesS Lange, C Diehm, H Darius, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1993
Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled studyH O Altstaedt, B Berzewski, H K Breddin, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]H Heidrich, W Rogatti, E Altmann, et al.
Journal of Internal Medicine|December 24, 2010
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial diseaseR H Böger, H G Endres, E Schwedhelm, et al.
Neuroepidemiology|August 31, 2013
A consecutive and prospective stroke database covers the state of Baden-Wuerttemberg with 10.8 million inhabitants in GermanyC Gumbinger, B Reuter, H Wiethölter, et al.
Journal of Developmental Origins of Health and Disease|January 18, 2019
Pregnancy stress, healthy pregnancy and birth outcomes - the need for early preventative approaches in pregnant Australian Indigenous women: a prospective longitudinal cohort studyB L Mah, K G Pringle, L Weatherall, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Deutsche Medizinische Wochenschrift (1946)|October 30, 2008
[Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease]H Darius, H J Trampisch, D Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)|May 19, 1989
[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]C Diehm, O Abri, G Baitsch, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1983
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases]H U Comberg, E J Janssen, C Diehm, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 4, 2004
High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetesS Lange, C Diehm, H Darius, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1993
Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled studyH O Altstaedt, B Berzewski, H K Breddin, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]H Heidrich, W Rogatti, E Altmann, et al.
Journal of Internal Medicine|December 24, 2010
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial diseaseR H Böger, H G Endres, E Schwedhelm, et al.
Neuroepidemiology|August 31, 2013
A consecutive and prospective stroke database covers the state of Baden-Wuerttemberg with 10.8 million inhabitants in GermanyC Gumbinger, B Reuter, H Wiethölter, et al.
Journal of Developmental Origins of Health and Disease|January 18, 2019
Pregnancy stress, healthy pregnancy and birth outcomes - the need for early preventative approaches in pregnant Australian Indigenous women: a prospective longitudinal cohort studyB L Mah, K G Pringle, L Weatherall, et al.
Pageof 17